Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Recombinant Protein Therapeutics CDMO Market

Recombinant Protein Therapeutics CDMO Market Share

Report ID: GMI8819
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Recombinant Protein Therapeutics CDMO Market Share

The recombinant protein therapeutics CDMO industry is characterized by a diverse mix of players, ranging from multinational corporations to small companies. Large multinational CDMOs, such as Lonza Group, Catalent, and WuXi Biologics, dominate a significant portion of the market share. These companies offer comprehensive services spanning from early-stage development to commercial-scale manufacturing, leveraging their global footprint, extensive infrastructure, and diversified service offerings to cater to a wide range of client needs.

Recombinant Protein Therapeutics CDMO Market Companies

Prominent players operating in the recombinant protein therapeutics CDMO industry include:

Batavia Biosciences B.V.
BIOVIAN
Catalent, Inc
Curia Global, Inc.
Enzene Biosciences Ltd
FUJIFILM Diosynth Biotechnologies
HALIX B.V.
Lonza
Richter-Helm BioLogics
WuXi Biologics

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Recombinant protein therapeutics CDMO market size was USD 21 billion in 2023 and is expected to register 14% CAGR from 2024-2032 owing to Increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders worldwide.

Recombinant protein therapeutics CDMO industry from the mammalian segment recorded over 61.5% share in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to being preferred to produce complex protein therapeutics such as cytokines and growth factors.

North America recombinant protein therapeutics CDMO industry reached USD 8.5 billion in 2023 and is expected to register a commendable CAGR from 2024-2032 due to access to advanced technologies, state-of-the-art infrastructure, and cutting-edge research capabilities in the region.

Batavia Biosciences B.V., BIOVIAN, Catalent, Inc, Curia Global, Inc., Enzene Biosciences Ltd, FUJIFILM Diosynth Biotechnologies, HALIX B.V., Lonza, Richter-Helm BioLogics, and WuXi Biologics, are some of the major Recombinant Protein Therapeutics CDMO companies worldwide.